207 related articles for article (PubMed ID: 22728334)
1. Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.
Geetha T; Langlais P; Caruso M; Yi Z
J Endocrinol; 2012 Sep; 214(3):437-43. PubMed ID: 22728334
[TBL] [Abstract][Full Text] [Related]
2. Quantitative phosphoproteomics reveals novel phosphorylation events in insulin signaling regulated by protein phosphatase 1 regulatory subunit 12A.
Zhang X; Ma D; Caruso M; Lewis M; Qi Y; Yi Z
J Proteomics; 2014 Sep; 109():63-75. PubMed ID: 24972320
[TBL] [Abstract][Full Text] [Related]
3. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.
Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF
J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289
[TBL] [Abstract][Full Text] [Related]
4. Site-specific phosphorylation of protein phosphatase 1 regulatory subunit 12A stimulated or suppressed by insulin.
Chao A; Zhang X; Ma D; Langlais P; Luo M; Mandarino LJ; Zingsheim M; Pham K; Dillon J; Yi Z
J Proteomics; 2012 Jun; 75(11):3342-50. PubMed ID: 22516431
[TBL] [Abstract][Full Text] [Related]
5. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
Ge Y; Yoon MS; Chen J
J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway.
Wu WL; Gan WH; Tong ML; Li XL; Dai JZ; Zhang CM; Guo XR
Mol Genet Metab; 2011 Mar; 102(3):374-7. PubMed ID: 21185755
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.
Arvisais E; Hou X; Wyatt TA; Shirasuna K; Bollwein H; Miyamoto A; Hansen TR; Rueda BR; Davis JS
Mol Endocrinol; 2010 Mar; 24(3):632-43. PubMed ID: 20160123
[TBL] [Abstract][Full Text] [Related]
8. Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation.
Law NC; Hunzicker-Dunn ME
J Biol Chem; 2016 Feb; 291(9):4547-60. PubMed ID: 26702053
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).
Maeno Y; Li Q; Park K; Rask-Madsen C; Gao B; Matsumoto M; Liu Y; Wu IH; White MF; Feener EP; King GL
J Biol Chem; 2012 Feb; 287(7):4518-30. PubMed ID: 22158866
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway.
Law NC; White MF; Hunzicker-Dunn ME
J Biol Chem; 2016 Dec; 291(53):27160-27169. PubMed ID: 27856640
[TBL] [Abstract][Full Text] [Related]
12. Nexilin, a cardiomyopathy-associated F-actin binding protein, binds and regulates IRS1 signaling in skeletal muscle cells.
Lee A; Hakuno F; Northcott P; Pessin JE; Rozakis Adcock M
PLoS One; 2013; 8(1):e55634. PubMed ID: 23383252
[TBL] [Abstract][Full Text] [Related]
13. Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE.
Hage Hassan R; Pacheco de Sousa AC; Mahfouz R; Hainault I; Blachnio-Zabielska A; Bourron O; Koskas F; Górski J; Ferré P; Foufelle F; Hajduch E
J Biol Chem; 2016 Feb; 291(6):3019-29. PubMed ID: 26698173
[TBL] [Abstract][Full Text] [Related]
14. HC toxin (a HDAC inhibitor) enhances IRS1-Akt signalling and metabolism in mouse myotubes.
Tan HW; Sim AY; Huang SL; Leng Y; Long YC
J Mol Endocrinol; 2015 Dec; 55(3):197-207. PubMed ID: 26373795
[TBL] [Abstract][Full Text] [Related]
15. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
16. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.
Tremblay F; Marette A
J Biol Chem; 2001 Oct; 276(41):38052-60. PubMed ID: 11498541
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells.
Wiza C; Herzfeld de Wiza D; Nascimento EB; Lehr S; Al-Hasani H; Ouwens DM
Diabetologia; 2013 May; 56(5):1118-28. PubMed ID: 23460019
[TBL] [Abstract][Full Text] [Related]
18. Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight.
Jensen CB; Martin-Gronert MS; Storgaard H; Madsbad S; Vaag A; Ozanne SE
PLoS One; 2008; 3(11):e3738. PubMed ID: 19011679
[TBL] [Abstract][Full Text] [Related]
19. Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition.
Leroy C; Ramos P; Cornille K; Bonenfant D; Fritsch C; Voshol H; Bentires-Alj M
Breast Cancer Res; 2016 Apr; 18(1):41. PubMed ID: 27048245
[TBL] [Abstract][Full Text] [Related]
20. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
Tzatsos A; Kandror KV
Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
